Related Experiment Video
Updated: Apr 7, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Can whole-exome sequencing data be used for linkage analysis?
Steven Gazal1,2, Simon Gosset1,3, Edgard Verdura4,5
1INSERM, IAME, UMR 1137, Paris, France.
Whole-exome sequencing (WES) effectively identifies disease-causing variants. Integrating linkage analysis with WES data significantly reduces false positives, improving diagnostic efficiency for monogenic disorders.
Area of Science:
- Genetics
- Genomic Medicine
Background:
- Whole-exome sequencing (WES) is crucial for identifying causal variants in monogenic disorders.
- WES data often yields extensive candidate variants, including sequencing errors (false positives).
- Reducing candidate variant lists is essential for efficient genetic diagnosis.
Purpose of the Study:
- To evaluate the efficacy of linkage analysis using common polymorphisms from WES data.
- To compare WES-derived linkage analysis with SNP chip data for variant filtering.
- To assess the cost-effectiveness of using WES data for linkage analysis in genetic studies.
Main Methods:
- Simulations were performed on two pedigrees with dominant and recessive traits.
- Linkage analysis was conducted using common single nucleotide polymorphisms (SNPs) extracted from WES data.
- Performance was compared between WES-derived SNPs and SNP chip data for excluding genomic regions.
Main Results:
- WES-derived SNPs and SNP chip data demonstrated similar performance in excluding genomic regions.
- No significant advantage was observed when using SNP chip data over WES-derived common SNPs.
- Linkage information from WES common polymorphisms halved the candidate variant list in real WES data analysis.
Conclusions:
- Linkage analysis using common polymorphisms from WES data is a powerful strategy.
- This approach effectively reduces the number of false-positive candidate variants.
- Integrating WES linkage analysis offers a cost-effective method for improving genetic diagnoses.
More Related Videos
05:51A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Sanger Sequencing